Health System AI Committee Approval Process: Faster Review Without Lower Standards

Review depth scales with risk

The approach in this guide has four stages. Each stage removes a source of delay without removing a safeguard.

Where approval time is usually lost

Long approval cycles are often a result of how review is organized rather than how rigorous it is. When a committee reviews every request the same way, the work is spread evenly instead of concentrated where the risk is.

Common sources of delay include:

• Every proposed tool receives the same depth of review, regardless of what it can affect.
• Requests arrive in different formats, so reviewers must ask for missing information before they can begin.
• Reviews happen one after another instead of at the same time.
• Approval criteria are decided case by case, which reopens settled questions.
• An approval ends the process, so there is no routine check that the tool stays within what was approved.

Each of these can be addressed by changing the structure of review. None requires lowering the bar for approval.

Translate risk into review depth

Start by assigning every proposed tool a risk tier. The tier is based on what the tool can affect, and it should be assigned before detailed review begins. The tier then determines how much review the tool receives.

Standardize clinical AI tool intake and vetting

Use one standard intake process and one evidence packet for every request. When all requests arrive in the same form, reviewers can begin immediately instead of reconciling different submissions.

Reuse evidence where nothing has changed

Evidence that has already been collected should not be requested again. If a tool, its configuration, and its intended use are unchanged, the existing packet can be carried forward into the new review. Reviewers then focus on what is new.

What a standard packet can cover

Your committee defines the contents. A packet commonly records:

• The intended use and the clinical or operational owner of the tool.
• The assigned risk tier and the reasoning behind it.
• The data the tool will access and the systems it will connect to.
• The users and workflows the tool is meant to support.
• Supporting documentation and evidence for each review discipline.

Run reviews in parallel and keep the non-negotiables

Once a request is tiered and the packet is complete, the required reviews can run at the same time. Clinical, privacy, security, legal, and other reviewers each work from the same packet instead of waiting for the previous reviewer to finish.

Set approval criteria in advance

Define what the committee requires before requests arrive. When criteria are written down for each risk tier, reviewers know what evidence is expected, requesters know what to provide, and decisions are consistent from one request to the next.

Keep the non-negotiables

Speed comes from structure, not from waiving requirements. The criteria that apply to a tool at a given tier stay in force, and a request that does not meet them is not approved because the schedule is tight. Parallel review changes when the work happens, not what the work must establish.

Make conditional approvals enforceable and verifiable

A conditional approval lets a tool go into use within defined limits. It is only as reliable as the committee's ability to confirm that those limits are respected after the decision.

Record the conditions of approval

Each decision should state what is approved and under what conditions. Conditions should be specific enough to be checked, for example:

• The approved use and the scope in which the tool may operate.
• The data and systems the tool is permitted to access.
• The users or workflows for which it is approved.
• Any follow-up the committee requires before or after launch.

Verify scope at runtime

For AI agents, verification means confirming while the tool operates that it stays within approved scope. Runtime permissions define what the tool can do, policy enforcement applies the committee's conditions as they occur, and audit logging produces evidence that the committee can review later.